[1] Bucci M, Borra R, Nagren K,et al.Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans[J].Cardiovasc Ther,2012,30(6):333-341.
[2] 宋鹏,王曙霞,汪晶晶.64排螺旋CT冠脉成像在冠心病诊断中的应用价值[J].中西医结合心脑血管病杂志,2012,10(2):137-139.
[3] Zhou X, Li C, Xu W, et al.Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress,apoptosis,and inflammation[J].PLoS One,2012,7(7):e40424.
[4]焦衡忠.噻氯匹啶与低分子肝素治疗不稳定性心绞痛的临床观察[J]. 医学临床研究,2005,22(12):1743-1744.
[5] 田峰,于虎,陈韵岱,等.国产阿加曲班在择期经皮冠状动脉介入治疗中应用的安全性和有效性[J]. 中华心血管病杂志,2013,41(6):480-483.
[6] 黎艺毅,王正东,陈坚,等.尼可地尔对不稳定型心绞痛患者PCI术后心肌损伤的影响[J]. 医学临床研究, 2015,32(11):2179-2181.
[7] 邵帅.普罗布考和曲美他嗪对不稳定型心绞痛患者PCI术后心肌损伤、炎症反应及内皮功能的影响[J].天津: 天津医科大学,2012.
[8] Casino PR, Kilcoyne CM, Quyyumi AA, et al. The role of nitric oxide in endotheliumdependent vasodilation of hyercholesterolemic patients[J]. Circulation, 1993,88(6):2541-2547.
[9] Saito M, Ishimitsu T, Minami J, et al. Relations of plasma highsensitivity Creactive protein to traditional cardiovascular risk factors[J]. Atherosclerosis, 2003, 167(11):73-79.
[10] Schumacher A, Seljeflot I, Sommervoll L, et al. Increased levels of endothelial haemostatic markers in patients with coronary heart disease[J].Thromb Res, 2002,105(1):25231.
[11] 石昭昭,李广平,邵帅,等.普罗布考对不稳定性心绞痛患者PCI治疗前后vWF、sP-S和IgG-ACA的影响[J]. 天津医科大学学报,2012,18(1):67-69.
[12] 梅颍,赵俊梅.养心氏片联合曲美他嗪治疗冠心病心绞痛并发室性早搏的临床疗效分析[J]. 世界中医药,2014,9(9):1184-1185.
[13] 刘帅,刘彤,富华颖,等.普罗布考在心血管疾病中的应用进展[J]. 中国心血管杂志,2013,18(8):73-75. |
2017, Vol. 34 
